Created with Sketch.
37 minutes | Jun 18, 2022
#48 - Alex Blyth: Founder & CEO, LifT BioSciences
30 minutes | May 21, 2022
#47 - Andrew Hall: CEO of IMV Inc.
40 minutes | Apr 18, 2022
#46 - Kevin Lee: CEO of Bicycle Biotherapeutics
Kevin Lee, CEO of Bicycle Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Bicycle Therapeutics is working on developing a new class of medicines, called Bicycles, for diseases that are underserved by existing therapeutics.
27 minutes | Mar 26, 2022
#45 - Reenie McCarthy: CEO of Stealth BioTherapeutics
BioBoss host John Simboli speaks with Reenie McCarthy, CEO of Stealth BioTherapeutics, headquartered in Needham, MA.. Hear Reenie's thoughts about leadership in biopharma and how Stealth Biotherapeutics is working on developing therapies to treat the mitochondrial dysfunction associated with genetic mitochondrial diseases and many common age-related diseases.
41 minutes | Feb 5, 2022
#44 - Yochi Slonim: Founder & CEO, Anima Biotech
BioBoss host John Simboli speaks with Yochi Slonim, founder and CEO of Anima Biotech, headquartered in Boston with R&D in Tel Aviv.. Hear Yochi's thoughts about leadership in biopharma and how Anima Biotech is working on a novel approach for the discovery of small molecules that selectively control mRNA translation as a new strategy against undruggable proteins.
33 minutes | Jan 8, 2022
#43 - Clive Richardson: CEO of Akari Therapeutics
BioBoss host John Simboli speaks with Clive Richardson, CEO of Akari Therapeutics, headquartered in London with offices in New York. Hear Clive's thoughts about leadership in biopharma and how Akari Therapeutics is working to develop life-transforming treatments for autoinflammatory diseases involving the complement and leukotriene pathways
1 minutes | Dec 28, 2021
Welcome to Season 4 of BioBoss
BioBoss podcast host John Simboli reflects on the success of seasons 1, 2 and 3 and welcomes listeners to listen in on his conversations about leadership with biopharma founders and CEOs in BioBoss season 4.
38 minutes | Dec 4, 2021
#42 - Stefan König: CEO of George Medicines
BioBoss host John Simboli speaks with Stefan König , CEO of George Medicines, headquartered in London. Hear Stefan’s thoughts about leadership in biopharma and how George Medicines is working to extend and improve the lives of people suffering from the world’s leading causes of death and disability—including hypertension, cardiovascular disease and type 2 diabetes
38 minutes | Oct 29, 2021
#41 - Derek Maetzold: CEO of Castle Biosciences
Derek Maetzold, CEO of Castle Biosciences shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Castle is leveraging its expertise in cancer genomics and the use of artificial intelligence to improve patient outcomes.
34 minutes | Oct 2, 2021
#40 - Bob Cobuzzi - CEO of Diffusion Pharmaceuticals
Bob Cobuzzi, Chief Executive Officer of Diffusion Pharmaceuticals,speaks with BioBoss John Simboli about leadership and how Diffusion Pharmaceuticals is working to develop novel therapies that enhance the body’s ability to deliver oxygen to the areas where it is needed most.
39 minutes | Sep 12, 2021
#39 - Panna Sharma - CEO of Lantern Therapeutics
Panna Sharma, CEO of Lantern Pharma, headquartered in Dallas, Texas, shares his thoughts with BioBoss host John Simboli about leadership and how Lantern is working at the intersection of artificial intelligence, genomics and machine learning to advance precision oncology therapies.
45 minutes | Jul 31, 2021
#38 - Nandan Padukone: CEO of IM Therapeutics
Nandan Padukone, CEO of IM Therapeutics, headquartered in Woburn, Massachusetts, shares his thoughts with BioBoss host John Simboli about leadership and how IM Therapeutics is targeting the root cause of autoimmunity with therapeutic design directed at human leukocyte antigens.
39 minutes | Jul 10, 2021
#37 - Matthew Gline: CEO of Roivant Sciences
31 minutes | May 30, 2021
#36 - Koen De Witte: Managing Director, ReMYND
Koen De Witte, managing director of reMYND NV, headquartered in Leuven, Belgium, shares his thoughts with BioBoss host John Simboli about leadership and how reMYND is advancing treatments for Alzheimer’s, diabetes and other diseases caused by cellular dysfunction.
37 minutes | May 1, 2021
#35 - Lanny Sun: Co-founder, Silicon Therapeutics
Lanny Sun, co-founder of Silicon Therapeutics, recently acquired by Roivant Sciences. speaks with corporate branding veteran John Simboli about leadership in biopharma. Lanny also discusses how Silicon Therapeutics, now part of Roivant Drug Discovery, is advancing its chip-to-clinic, computational quantum physics-based approach to pioneer a new path for drug design of medicines to improve the lives of patients
37 minutes | Apr 3, 2021
#34 - Joan Perelló: Co-Founder and CEO of Sanifit
Joan Perelló, co-founder and CEO of Sanifit, shares his thoughts with BioBoss host John Simboli about leadership and how Sanifit is pursuing the development of treatments for progressive vascular calcification disorders.
27 minutes | Mar 13, 2021
#33 - Saiid Zarrabian: CEO of Kintara Therapeutics
Saiid Zarrabian, President and CEO of Kintara Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership and how Kintara is pursuing the development of new cancer therapies for patients with rare unmet medical needs.
32 minutes | Feb 7, 2021
#32 - John Temperato: CEO of 9 Meters Biopharma
John Temperato, President and Chief Executive Officer of 9 Meters Biopharma, speaks with BioBoss host John Simboli about leadership in biopharma and how 9 Meters is advancing drug candidates for patients with rare and unmet gastrointestinal disorders including short bowel syndrome and celiac disease.
40 minutes | Jan 10, 2021
#31 - Shawn Singh: CEO of VistaGen Therapeutics
Shawn Singh, CEO of VistaGen, speaks with BioBoss host John Simboli about leadership and VistaGen's working to develop a new generation of medications for anxiety, depression and other central nervous system disorders.
1 minutes | Jan 6, 2021
Welcome to Season 3 of BioBoss
BioBoss podcast host John Simboli reflects on the success of seasons 1 and 2 and welcomes listeners to listen in on his conversations about leadership with biopharma founders and CEOs in BioBoss season 3.
Terms of Service
Do Not Sell My Personal Information
© Stitcher 2022